Combined Therapeutics, Inc.
Immunological therapeutics combining multiple therapeutic modalities to treat infectious diseases and immune disorders
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2016
- Latest Form D
- $250K, Dec 2017
- Total capital
- $250K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $250K
- 1 Form D · last Dec 2017
- 107 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- 10 pending · first 2022
- Rank in peer group#269 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$250K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#269 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Romain MicolResearcherExecutive Officer, DirectorLinked by 5 patents
- Daniel AndersonDirectorNamed in SEC Form D filings
- Justine RyanDirectorNamed in SEC Form D filings
- Pierre MatussiereDirectorNamed in SEC Form D filings
- Robert LangerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 15- PendingCompositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsUSPTOApplication 19048760
- PendingCompositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In TissueUSPTOApplication 18984898
- GrantedCompositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsUSPTOUS 12,220,456
Show all 15 patent records
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsMay 29, 2025 · Application 19048760Pending
- Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In TissueApr 24, 2025 · Application 18984898Pending
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsFeb 11, 2025 · US 12,220,456Granted
- Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In TissueJan 14, 2025 · US 12,195,746Granted
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsMar 19, 2024 · US 11,931,409Granted
- Compositions And Methods For Improved VaccinationJan 25, 2024 · Application 18018759Pending
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsMar 7, 2023 · US 11,596,685Granted
- Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In TissueJun 14, 2022 · US 11,359,212Granted
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsDec 3, 2020 · Application 16970888Pending
- Compositions and Processes for Targeted Delivery, Expression and Modulation of Coding Ribonucleic Acids in TissueApplication 62632056Pending
- Compositions And Methods For Improved VaccinationApplication PCTUS2021043975Pending
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsApplication PCTUS2021019028Pending
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsApplication 63059458Pending
- Compositions And Methods For Organ-protective Expression And Modulation Of Coding Ribonucleic AcidsApplication 62979619Pending
- Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribounucleic Acids In TissueApplication PCTUS2018049772Pending
Related companies, and why
- Pike Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- NKore Biotherapeutics, LLCSimilar federal contract value in Biotech · null in contracts
- Alphageneron Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- EvonetixSimilar federal contract value in Biotech · null in contracts
- A2 THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- HUNTERIAN MEDICINE LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .